These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7205848)

  • 1. Nutritional status and general immune competence in patients with head and neck cancer.
    Brookes GB; Clifford P
    J R Soc Med; 1981 Feb; 74(2):132-9. PubMed ID: 7205848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
    Bier J; Bitter K; Nicklisch U
    J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of immune and nutritional status with wound complications in patients undergoing vascular operations.
    Casey J; Flinn WR; Yao JS; Fahey V; Pawlowski J; Bergan JJ
    Surgery; 1983 Jun; 93(6):822-7. PubMed ID: 6857500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional status--a prognostic indicator in head and neck cancer.
    Brookes GB
    Otolaryngol Head Neck Surg; 1985 Feb; 93(1):69-74. PubMed ID: 3920627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional assessment of the head and neck cancer patient.
    Lambert MJ
    Otolaryngol Head Neck Surg (1979); 1980; 88(6):695-9. PubMed ID: 7208037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutritional status in head and neck cancer: observations and implications.
    Brookes GB
    Clin Otolaryngol Allied Sci; 1983 Jun; 8(3):211-20. PubMed ID: 6883785
    [No Abstract]   [Full Text] [Related]  

  • 7. Dinitrochlorobenzene skin sensitization and peripheral lymphocyte count: predictors of survival in head and neck cancer.
    Maisel RH; Ogura JH
    Ann Otol Rhinol Laryngol; 1976; 85(4 Pt 1):517-22. PubMed ID: 949158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed hypersensitivity to DNCB and survival following radiation therapy in patients with solid malignant tumors.
    Hazra TA; Parks LC; Inalsingh A; Peeples W
    Radiology; 1975 May; 115(2):429-30. PubMed ID: 1144761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of perioperative nutrition, with and without arginine supplementation, on nutritional status, immune function, postoperative morbidity, and survival in severely malnourished head and neck cancer patients.
    van Bokhorst-De Van Der Schueren MA; Quak JJ; von Blomberg-van der Flier BM; Kuik DJ; Langendoen SI; Snow GB; Green CJ; van Leeuwen PA
    Am J Clin Nutr; 2001 Feb; 73(2):323-32. PubMed ID: 11157331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The usefulness of pretreatment DNCB in 85 patients with squamous cell carcinoma of the upper aerodigestive tract.
    Gilbert HA; Kagan AR; Miles J; Flores L; Nussbaum H; Rao AR; Chan P
    J Surg Oncol; 1978; 10(1):73-7. PubMed ID: 628221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial studies of immunocompetence in head and neck cancer patients undergoing radiation therapy.
    Stefano S; Kerman R; Abbate J
    AJR Am J Roentgenol; 1976 Apr; 126(4):880-6. PubMed ID: 179361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma.
    Lim WS; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
    Laryngoscope; 2017 Dec; 127(12):E437-E442. PubMed ID: 28561532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigations of unspecific immune reactivity in patients with head and neck carcinoma (author's transl)].
    Bier J; Nicklisch U
    Arch Otorhinolaryngol; 1981; 232(2):145-63. PubMed ID: 6973965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of skin testing with dinitrochlorobenzene in patients with head and neck cancer.
    Osoba D; Kersey PA; Clark RM; Rosen IB
    Can J Surg; 1980 Jan; 23(1):43-4. PubMed ID: 7363157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo anergy reversal with cimetidine in patients with cancer.
    Richtsmeier WJ; Eisele D
    Arch Otolaryngol Head Neck Surg; 1986 Oct; 112(10):1074-7. PubMed ID: 3755977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological status of patients in carcinoma head and neck.
    Vasenwala SM; Aziz M; Rattan A; Ahmad KN
    Indian J Cancer; 1989 Sep; 26(3):137-44. PubMed ID: 2630426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic evaluation and prognosis in patients with head and neck cancer.
    Hilal EY; Wanebo HJ; Pinsky CM; Middleman P; Strong EW; Oettgen HF
    Am J Surg; 1977 Oct; 134(4):468-73. PubMed ID: 303057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the immunology of head and neck cancer--a prognostic index. Preliminary communication.
    Parker R; Alexander S; Shaheen OH; Parkes P
    J Laryngol Otol; 1975 Jul; 89(7):687-95. PubMed ID: 1185059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of delayed cutaneous reactivity in head and neck cancer patients.
    Mandel MA; Kiehn CL
    Plast Reconstr Surg; 1974 Jan; 53(1):72-6. PubMed ID: 4588603
    [No Abstract]   [Full Text] [Related]  

  • 20. A study of T-lymphocytes and delayed cutaneous hypersensitivity reaction in patients with squamous cell carcinoma of head and neck region.
    Singh SN; Agrawal BM; Shanker R; Rajvanshi VS
    Indian J Cancer; 1979; 16(3-4):53-8. PubMed ID: 317272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.